To analyze whether CQ also induced these lethal lesions in other cancer cell lines we treated colon, breast, glioblastoma and head and neck cancer cell lines with this compound and then monitored the phosphorylation of H2AX (γH2AX), a sensitive and well-recognized marker of DSBs, by immunofluorescence. The gene discussed is H2AX; the disease is head and neck cancer.